A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer

JOURNAL ARTICLE published 19 December 2017 in Oncotarget

Authors: Kensaku Yoshida | Takuji Iwashita | Shinya Uemura | Akinori Maruta | Mitsuru Okuno | Nobuhiro Ando | Keisuke Iwata | Junji Kawaguchi | Tsuyoshi Mukai | Masahito Shimizu